A

Ascent Biomedical Ventures

50 employees

Ascent Biomedical Ventures is a financial organisation which is interested in investing in seed and early-stage biomedical technology

Investor insights

Sectors invested in

Health Care8
Biotechnology5
Therapeutics5
Healthcare2
Medical Device1
Telecommunications1
Hospitals1
Mobile Apps1
Elderly1
Healthtech1
Health Technology1
EVV1
Health IT1
Home Care Service Agencies1
Information Technology1
Software1
Scheduling Software1
mHealth1
Home Care Software1
Artificial discs (cervical and lumbar)1

Funding rounds participated in

$9M sweet spot round size

Most of their 16 investments are in rounds between $3.5M and $15M

Investor type

Venture Capital

Basic info

Industry

biotechnology research

Sectors

Angel Investment
Biotechnology
Financial Services

Date founded

2004

Investments made

P

Peerbridge Health Inc. raised $11M on November 19, 2019

Investors: Kinled Holding Ltd and Ascent Biomedical Ventures

U

Undisclosed raised $3.3M on May 1, 2015

Investors: Ascent Biomedical Ventures

e

eCaring raised $3.5M on April 16, 2014

Investors: Ascent Biomedical Ventures

U

Undisclosed raised $25M on December 3, 2013

Investors: Aperture Venture Partners, Prism Venture Partners, Charter Life Sciences and Ascent Biomedical Ventures

U

Undisclosed raised $12M on July 16, 2012

Investors: Ascent Biomedical Ventures

C

Cara Therapeutics raised $4.8M on May 21, 2012

Investors: Alta Partners, CT Innovation, Devon Park Bioventures, MVM Partners and Ascent Biomedical Ventures

U

Undisclosed raised $7M on April 29, 2011

Investors: Charter Life Sciences, Prism Venture Partners, Aperture Venture Partners, Western Technology and Ascent Biomedical Ventures

C

Cara Therapeutics raised $15M on July 21, 2010

Investors: MVM Partners, Alta Partners, Devon Park Bioventures, Mitsubishi Corporation, Rho Ventures and Ascent Biomedical Ventures

U

Undisclosed raised $5.1M on March 14, 2009

Investors: Partners HealthCare and Ascent Biomedical Ventures

C

Cara Therapeutics raised $12M on July 25, 2008

Investors: Devon Park Bioventures and Ascent Biomedical Ventures

FAQ